The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease
Open accessAbstract
AIMS: This preclinical study was aimed at determining whether pharmacological targeting of transcription factor NRF2, a master controller of many homeostatic genes, might provide a disease-modifying therapy in the animal model of Parkinson's disease (PD) that best reproduces the main hallmark of this pathology, that is, α-synucleinopathy, and associated events, including nigral dopaminergic cell death, oxidative stress, and neuroinflammation. RESULTS: Pharmacological activation of NRF2 was achieved at the basal ganglia by repurposing dimethyl fumarate (DMF), a drug already in use for the treatment of multiple sclerosis. Daily oral gavage of DMF protected nigral dopaminergic neurons against α-SYN toxicity and decreased astrocytosis and microgliosis after 1, 3, and 8 weeks from stereotaxic delivery to the ventral midbrain of recombinant adeno-associated viral vector expressing human α-synuclein. This protective effect was not observed in Nrf2-knockout mice. In vitro studies indicated that this neuroprotective effect was correlated with altered regulation of autophagy markers SQTSM1/p62 and LC3 in MN9D, BV2, and IMA 2.1 and with a shift in microglial dynamics toward a less pro-inflammatory and a more wound-healing phenotype. In postmortem samples of PD patients, the cytoprotective proteins associated with NRF2 expression, NQO1 and p62, were partly sequestered in Lewy bodies, suggesting impaired neuroprotective capacity of the NRF2 signature. INNOVATION: These experiments provide a compelling rationale for targeting NRF2 with DMF as a therapeutic strategy to reinforce endogenous brain defense mechanisms against PD-associated synucleinopathy. CONCLUSION: DMF is ready for clinical validation in PD. Antioxid. Redox Signal. 25, 61-77.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tobón-Velasco, J. C., Vázquez‐Victorio, G., Macías‐Silva, M., Cuevas, E., Ali, S. F., Maldonado, P. D., González-Trujano, M. E., Cuadrado, A., Pedraza‐Chaverrí, J., & Santamarı́a, A. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.040 · Cited by 44
Self-citationRetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
The mouse brain in stereotaxic coordinates
Konsman, J.-P. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00088-x · Cited by 4,045
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
The efficiency of systematic sampling in stereology and its prediction*
Gundersen, H. J. G., & Jensen, E. B. (1987) · Journal of Microscopy · doi:10.1111/j.1365-2818.1987.tb02837.x · Cited by 3,520
Komatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y.-S., Ueno, I., Sakamoto, A., Tong, K. I., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2021 · Cited by 2,288
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
Hayes, J. D., & Dinkova-Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,141
Nrf2–Keap1 defines a physiologically important stress response mechanism
Motohashi, H., & Yamamoto, M. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.003 · Cited by 1,725 · cited 5×
“A wealth of NRF2 activators has been identified that appear to disrupt the KEAP1/NRF2 interaction (28).”
InfluentialPharmacological Treatment of Parkinson Disease: A Review
Connolly, B. S., & Lang, A. E. (2014) · JAMA · doi:10.1001/jama.2014.3654 · Cited by 1,498
Jain, A., Lamark, T., Sjøttem, E., Bowitz Larsen, K., Atesoh Awuh, J., Øvervatn, A., McMahon, M., Hayes, J. D., & Johansen, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118976 · Cited by 1,472
Rushmore, T. H., Morton, M. R., & Pickett, C. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99004-6 · Cited by 1,464
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446
Lau, A., Wang, X.-J., Zhao, F., Villeneuve, N. F., Wu, T., Jiang, T., Sun, Z., White, E., & Zhang, D. D. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00248-10 · Cited by 849
Expression of Nrf2 in Neurodegenerative Diseases
Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T., & Jordan-Sciutto, K. L. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d6da9 · Cited by 760
Chhor, V., Le Charpentier, T., Lebon, S., Oré, M.-V., Celador, I. L., Josserand, J., Degos, V., Jacotot, E., Hagberg, H., Sävman, K., et al. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.02.005 · Cited by 647
Chen, P.-C., Vargas, M. R., Pani, A. K., Smeyne, R. J., Johnson, D. A., Kan, Y. W., & Johnson, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813361106 · Cited by 579
Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway
Hayes, J. D., McMahon, M., Chowdhry, S., & Dinkova-Kostova, A. T. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3221 · Cited by 539
Direct and indirect antioxidant properties of inducers of cytoprotective proteins
Dinkova-Kostova, A. T., & Talalay, P. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700195 · Cited by 535
Classic and New Animal Models of Parkinson's Disease
Blesa, J., Phani, S., Jackson-Lewis, V., & Przedborski, S. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/845618 · Cited by 505
The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation
Innamorato, N. G., Rojo, A. I., García-Yagüe, À. J., Yamamoto, M., de Ceballos, M. L., & Cuadrado, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.680 · Cited by 480
Self-citationThe Parkinson Study Group QE3 Investigators, Beal, M. F., Oakes, D., Shoulson, I., Henchcliffe, C., Galpern, W. R., Haas, R., Juncos, J. L., Nutt, J. G., Voss, T. S., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.131 · Cited by 408
Ishii, T., Itoh, K., Ruiz, E., Leake, D. S., Unoki, H., Yamamoto, M., & Mann, G. E. (2004) · Circulation Research · doi:10.1161/01.res.0000119171.44657.45 · Cited by 398
Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease
Rojo, A. I., Innamorato, N. G., Martín‐Moreno, A. M., De Ceballos, M. L., Yamamoto, M., & Cuadrado, A. (2010) · Glia · doi:10.1002/glia.20947 · Cited by 375
Self-citationWilms, H., Sievers, J., Rickert, U., Rostami-Yazdi, M., Mrowietz, U., & Lucius, R. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-30 · Cited by 344
Jazwa, A., Rojo, A. I., Innamorato, N. G., Hesse, M., Fernández-Ruiz, J., & Cuadrado, A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3731 · Cited by 327
Self-citationPekovic-Vaughan, V., Gibbs, J., Yoshitane, H., Yang, N., Pathiranage, D., Guo, B., Sagami, A., Taguchi, K., Bechtold, D., Loudon, A., et al. (2014) · Genes & Development · doi:10.1101/gad.237081.113 · Cited by 323
Nrf2—a therapeutic target for the treatment of neurodegenerative diseases
Johnson, D. A., & Johnson, J. A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.07.147 · Cited by 321
Cuadrado, A., Martín-Moldes, Z., Ye, J., & Lastres-Becker, I. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.540633 · Cited by 320
Self-citationGlycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease
Castellani, R., Smith, M. A., Richey, G. L., & Perry, G. (1996) · Brain Research · doi:10.1016/0006-8993(96)00729-9 · Cited by 315
Redox Control of Microglial Function: Molecular Mechanisms and Functional Significance
Rojo, A. I., McBean, G., Cindric, M., Egea, J., López, M. G., Rada, P., Zarkovic, N., & Cuadrado, A. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5745 · Cited by 309
Self-citationDimethyl fumarate in the treatment of relapsing–remitting multiple sclerosis: an overview
Bomprezzi, R. (2015) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285614564152 · Cited by 301
Antipsoriatic effect of fumaric acid derivatives
Altmeyer, P. J., Mattlies, U., Pawlak, F., Hoffmann, K., Frosch, P. J., Ruppert, P., Wassilew, S. W., Horn, T., Kreysel, H. W., Lutz, G., et al. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70121-0 · Cited by 300
Neural Heme Oxygenase-1 Expression in Idiopathic Parkinson's Disease
Schipper, H. M., Liberman, A., & Stopa, E. G. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6752 · Cited by 300
Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship
Xilouri, M., Brekk, O. R., & Stefanis, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8341-2 · Cited by 299
Kanninen, K., Heikkinen, R., Malm, T., Rolova, T., Kuhmonen, S., Leinonen, H., Ylä-Herttuala, S., Tanila, H., Levonen, A.-L., Koistinaho, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908397106 · Cited by 293
Borlongan, C., & Sanberg, P. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-05372.1995 · Cited by 270
Lastres-Becker, I., Ulusoy, A., Innamorato, N. G., Sahin, G., Rábano, A., Kirik, D., & Cuadrado, A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds143 · Cited by 263
Self-citationZhou, S.-F., Wang, Y.-Y., Zhe, H., Yang, Y., & He, Z. (2014) · Drug Design, Development and Therapy · doi:10.2147/dddt.s68872 · Cited by 231
Antioxidants in Translational Medicine
Schmidt, H. H. H. W., Stocker, R., Vollbracht, C., Paulsen, G., Riley, D., Daiber, A., & Cuadrado, A. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6393 · Cited by 228
Self-citationEffects of dimethyl fumarate on neuroprotection and immunomodulation
Albrecht, P., Bouchachia, I., Goebels, N., Henke, N., Hofstetter, H. H., Issberner, A., Kovacs, Z., Lewerenz, J., Lisak, D., Maher, P., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-163 · Cited by 227
Rojo, A. I., Salinas, M., Martín, D., Perona, R., & Cuadrado, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2111-04.2004 · Cited by 216
Self-citationTargeting Heme Oxygenase-1 for Neuroprotection and Neuroinflammation in Neurodegenerative Diseases
Jazwa, A., & Cuadrado, A. (2010) · Current Drug Targets · doi:10.2174/1389450111009011517 · Cited by 209
Self-citationAutophagy Regulates Phagocytosis by Modulating the Expression of Scavenger Receptors
Bonilla, D. L., Bhattacharya, A., Sha, Y., Xu, Y., Xiang, Q., Kan, A., Jagannath, C., Komatsu, M., & Eissa, N. T. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.026 · Cited by 190
Brennan, M. S., Matos, M. F., Li, B., Hronowski, X., Gao, B., Juhasz, P., Rhodes, K. J., & Scannevin, R. H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120254 · Cited by 188 · cited 5×
“A wealth of NRF2 activators has been identified that appear to disrupt the KEAP1/NRF2 interaction (28).”
InfluentialSelf-citationZhang, Z., Wang, S., Zhou, S., Yan, X., Wang, Y., Chen, J., Mellen, N., Kong, M., Gu, J., Tan, Y., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.09.022 · Cited by 188
In vivo modulation of the Parkinsonian phenotype by Nrf2
Burton, N. C., Kensler, T. W., & Guilarte, T. R. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.07.019 · Cited by 187
Kügler, S., Meyn, L., Holzmüller, H., Gerhardt, E., Isenmann, S., Schulz, J. B., & Bähr, M. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0929 · Cited by 185
Self-citationGan, L., Vargas, M. R., Johnson, D. A., & Johnson, J. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3049-12.2012 · Cited by 182
GDNF fails to exert neuroprotection in a rat -synuclein model of Parkinson's disease
Decressac, M., Ulusoy, A., Mattsson, B., Georgievska, B., Romero-Ramos, M., Kirik, D., & Bjorklund, A. (2011) · Brain · doi:10.1093/brain/awr149 · Cited by 178
Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra
Muiswinkel, F. L. V., de Vos, R. A. I., Bol, J. G. J. M., Andringa, G., Steur, E. N. H. J., Ross, D., Siegel, D. M., & Drukarch, B. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.010 · Cited by 176
DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent manner
Gillard, G. O., Collette, B., Anderson, J., Chao, J., Scannevin, R. H., Huss, D. J., & Fontenot, J. D. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.04.006 · Cited by 173
Self-citationBéraud, D., Hathaway, H. A., Trecki, J., Chasovskikh, S., Johnson, D. A., Johnson, J. A., Federoff, H. J., Shimoji, M., Mhyre, T. R., & Maguire-Zeiss, K. A. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9401-0 · Cited by 172
Kaidery, N. A., Banerjee, R., Yang, L., Smirnova, N. A., Hushpulian, D. M., Liby, K. T., Williams, C. R., Yamamoto, M., Kensler, T. W., Ratan, R. R., et al. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4491 · Cited by 170
Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis
Lastres-Becker, I., Innamorato, N. G., Jaworski, T., Rábano, A., Kügler, S., Van Leuven, F., & Cuadrado, A. (2014) · Brain · doi:10.1093/brain/awt323 · Cited by 160
Self-citationThe transcription factor Nrf2 as a new therapeutic target in Parkinson's disease
Cuadrado, A., Moreno-Murciano, P., & Pedraza‐Chaverrí, J. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/13543780802716501 · Cited by 145
Self-citationNrf2 participates in depressive disorders through an anti-inflammatory mechanism
Martín-de-Saavedra, M. D., Budni, J., Cunha, M. P., Gómez-Rangel, V., Lorrio, S., del Barrio, L., Lastres-Becker, I., Parada, E., Tordera, R. M., Rodrigues, A. L. S., et al. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.020 · Cited by 143
Self-citationAssociation of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease
von Otter, M., Landgren, S., Nilsson, S., Celojevic, D., Bergström, P., Håkansson, A. S., Nissbrandt, H., Droździk, M., Białecka, M. A., Kurzawski, M., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-36 · Cited by 143
Role of the K eap1/ N rf2 pathway in neurodegenerative diseases
Yamazaki, H., Tanji, K., Wakabayashi, K., Matsuura, S., & Itoh, K. (2015) · Pathology International · doi:10.1111/pin.12261 · Cited by 134
Xu, J., Shi, H., Zhang, C., Ren, M., Han, M., Wei, X., Zhang, X., & Lou, H. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.047 · Cited by 128
Proteasome Dysfunction Activates Autophagy and the Keap1-Nrf2 Pathway
Kageyama, S., Sou, Y., Uemura, T., Kametaka, S., Saito, T., Ishimura, R., Kouno, T., Bedford, L., Mayer, R. J., Lee, M., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.580357 · Cited by 116
Freitas, A. E., Egea, J., Buendía, I., Gómez‐Rangel, V., Parada, E., Navarro, E., Casas, A. I., Wojnicz, A., Ortiz, J. A., Cuadrado, A., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9182-6 · Cited by 115
Self-citationYoo, M. S., Chun, H. S., Son, J. J., DeGiorgio, L. A., Kim, D. J., Peng, C., & Son, J. H. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00586-7 · Cited by 107
p62/SQSTM1-Dependent Autophagy of Lewy Body-Like α-Synuclein Inclusions
Watanabe, Y., Tatebe, H., Taguchi, K., Endo, Y., Tokuda, T., Mizuno, T., Nakagawa, M., & Tanaka, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052868 · Cited by 106
Taschenberger, G., Garrido, M., Tereshchenko, Y., Bähr, M., Zweckstetter, M., & Kügler, S. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0926-8 · Cited by 103
Self-citationChoi, H. K., Won, L., Roback, J. D., Wainer, B. H., & Heller, A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.8943 · Cited by 96
Levodopa toxicity in foetal rat midbrain neurones in culture
Mena, M. A., Pardo, B., Paı́no, C. L., & de Yébenes, J. G. (1993) · Neuroreport · doi:10.1097/00001756-199304000-00025 · Cited by 92
Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson’s disease – a multicenter study
von Otter, M., Bergström, P., Quattrone, A., Marco, E. V. D., Annesi, G., Söderkvist, P., Wettinger, S. B., Droździk, M., Białecka, M. A., Nissbrandt, H., et al. (2014) · BMC Medical Genetics · doi:10.1186/s12881-014-0131-4 · Cited by 78
Rostami‐Yazdi, M., Clement, B., Schmidt, T., Schinor, D., & Mrowietz, U. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.197 · Cited by 76
Activation of autophagy in macrophages by pro-resolving lipid mediators
Prieto, P., Rosales-Mendoza, C. E., TerrÓn, V., Toledano, V., Cuadrado, A., LÓpez-Collazo, E., Bannenberg, G., Martín-Sanz, P., FernÁndez-Velasco, M., & BoscÁ, L. (2015) · Autophagy · doi:10.1080/15548627.2015.1078958 · Cited by 71
Self-citationSulforaphane induces autophagy through ERK activation in neuronal cells
Jo, C., Kim, S., Cho, S., Choi, K. J., Yun, S., Koh, Y. H., Johnson, G. V. W., & Park, S. I. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.06.036 · Cited by 69
Bentea, E., der Perren, A. V., Liefferinge, J. V., Arfani, A. E., Albertini, G., Demuyser, T., Merckx, E., Michotte, Y. M., Smolders, I. J., Baekelandt, V., et al. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00068 · Cited by 58
Kwak, M.-K., & Kensler, T. W. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.043 · Cited by 56
p 62 Deficiency Enhances α‐Synuclein Pathology in Mice
Tanji, K., Odagiri, S., Miki, Y., Maruyama, A., Nikaido, Y., Mimura, J., Mori, F., Warabi, E., Yanagawa, T., Ueno, S., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12214 · Cited by 49
Gasperini, C., Ruggieri, S., & Tortorella, C. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s53285 · Cited by 49
Anti-Inflammatory Dimethylfumarate: A Potential New Therapy for Asthma?
Seidel, P., & Roth, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/875403 · Cited by 40
Choi, K., Chen, J., MITRA, S. P., & Sarna, S. K. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.074 · Cited by 28
Successful treatment of discoid lupus erythematosus with fumaric acid esters
Tsianakas, A., Herzog, S., Landmann, A., et al. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.12.004 · Cited by 22
Brennan, M. S., Allaire, N., Huss, D. J., Cullen, P. F., Thai, A., Szak, S. T., Thomas, A. M., Gianni, D., Carulli, J. P., Fontenot, J. D., et al. (2014) · Neurology · doi:10.1212/wnl.82.10_supplement.p1.206 · Cited by 6
Self-citation
Research works printed but not linked: 1
- 10.1016/j.bbrc.2011.01.025 · doi:10.1016/j.bbrc.2011.01.025
Cited by
Sies, H., Berndt, C., & Jones, D. P. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045037 · Cited by 3,520
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Self-citationTherapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Cuadrado, A., Rojo, A. I., Wells, G., Hayes, J. D., Cousin, S. P., Rumsey, W. L., Attucks, O. C., Franklin, S., Levonen, A.-L., Kensler, T. W., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0008-x · Cited by 1,438
Self-citationInflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
Pajares, M., I. Rojo, A., Manda, G., Boscá, L., & Cuadrado, A. (2020) · Cells · doi:10.3390/cells9071687 · Cited by 779
Self-citationTu, W., Wang, H., Li, S., Liu, Q., & Sha, H. (2019) · Aging and disease · doi:10.14336/ad.2018.0513 · Cited by 707
Metadata
- Authors
- Lastres-Becker, I., García-Yagüe, A. J., Scannevin, R. H., Casarejos, M. J., Kügler, S., Rábano, A., & Cuadrado, A.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2016-07-10
- Volume
- 25
- Issue
- 2
- Pages
- 61-77
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2309675626
- Cited by
- 274
- References
- 79
- FWCI
- 18.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.